Finding 1057592 (2022-014)

Material Weakness
Requirement
E
Questioned Costs
-
Year
2022
Accepted
2024-08-15
Audit: 317252
Organization: Unity Health Care, Inc. (MD)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The Corporation failed to provide eligibility data and documentation for WIC program applicants, hindering compliance assessment.
  • Impacted Requirements: Key eligibility criteria related to residency, income, and nutritional risk were not adequately documented, risking benefits to ineligible individuals.
  • Recommended Follow-Up: Establish formal internal controls and documentation processes for eligibility assessments to ensure compliance and accountability.

Finding Text

Criteria: Applicants for WIC program benefits are screened at WIC clinic sites to determine their WIC eligibility. To be certified eligible, they must meet the eligibility criteria defined at 7 CFR sections 246.7(c), (d), (e), (g), and (l) related to Category, Identity and Residency, Income, and Nutritional Risk. Condition: During our testing of eligibility, the Corporation was unable to provide eligibility data for the period January 1, 2022 through March 31, 2022 and therefore we were unable to assess eligibility compliance requirements during that period. In addition, the Corporation was unable to provide support that eligibility assessments performed were reviewed. Below is a summary of our findings: • For 6 of the 40 samples, proper segregation of duties was not maintained as the staff person who determined income eligibility was the same staff person who completed the medical risk assessment. • For 23 of the 40 samples, the Corporation was unable to provide support to verify the applicant signed the Rights and Obligations statement. • For 3 out of the 40 samples, the Corporation was unable to provide documentation that the applicant met the residency eligibility requirement. • For 27 out of the 40 samples, the Corporation was unable to provide documentation that the applicant met the income eligibility requirement. • For 14 out of the 40 samples, the Corporation was unable to provide documentation that the applicant met the category eligibility requirement. • For 9 out of the 40 samples, the Corporation was unable to provide documentation that the applicant met the nutritional risk eligibility requirement. • For 1 out of the 40 samples, it was noted the certified applicant did not provide documentation to support the required residency requirement. Participants who do not provide residency documentation are required to provide residency documentation within 30 days. The Corporation was unable to provide evidence the participant provided residency support within 30 days. • For all 40 samples, the Corporation was unable to provide support that the eligibility assessments performed were reviewed. Cause: The Corporation did not have formal policies and procedures over subrecipient monitoring. Effect or Potential Effect: Lack of strict adherence to documentation requirements may have resulted in the Organization providing benefits to ineligible beneficiaries. Questioned costs: None Context: We tested a sample of 40 participants determined to be eligible and noted the Corporation was not able to produce sufficient and appropriate evidence that eligibility assessments performed were reviewed, and found exceptions as noted in the condition. This is a condition identified per review of the Corporation’s compliance with specified requirements using a statistically valid sample. Repeat finding: No Recommendation: We recommend the Corporation establish formal internal controls, and documentation of their performance, relating to assessing eligibility of participants. View of Responsible Officials: Due to a change in reporting systems used to assess eligibility, the Corporation did not have access to the eligibility data for the period January 1, 2022 through March 31, 2022. Due to turnover of several key financial executives and personnel and lack of formal documentation of current policies and procedures, the Corporation did not maintain sufficient or appropriate evidence that eligibility assessments performed were reviewed.

Categories

Subrecipient Monitoring Eligibility Internal Control / Segregation of Duties

Other Findings in this Audit

  • 481113 2022-004
    Material Weakness Repeat
  • 481114 2022-005
    Material Weakness Repeat
  • 481115 2022-006
    Material Weakness Repeat
  • 481116 2022-007
    Significant Deficiency Repeat
  • 481117 2022-009
    Material Weakness Repeat
  • 481118 2022-010
    Significant Deficiency Repeat
  • 481119 2022-011
    Significant Deficiency Repeat
  • 481120 2022-004
    Material Weakness Repeat
  • 481121 2022-005
    Material Weakness Repeat
  • 481122 2022-006
    Material Weakness Repeat
  • 481123 2022-007
    Significant Deficiency Repeat
  • 481124 2022-009
    Material Weakness Repeat
  • 481125 2022-010
    Significant Deficiency Repeat
  • 481126 2022-011
    Significant Deficiency Repeat
  • 481127 2022-004
    Material Weakness Repeat
  • 481128 2022-005
    Material Weakness Repeat
  • 481129 2022-006
    Material Weakness Repeat
  • 481130 2022-007
    Significant Deficiency Repeat
  • 481131 2022-012
    Significant Deficiency
  • 481132 2022-013
    Significant Deficiency
  • 481133 2022-016
    Significant Deficiency
  • 481134 2022-017
    Significant Deficiency
  • 481135 2022-004
    Material Weakness Repeat
  • 481136 2022-005
    Material Weakness Repeat
  • 481137 2022-006
    Material Weakness Repeat
  • 481138 2022-008
    Significant Deficiency Repeat
  • 481139 2022-009
    Material Weakness Repeat
  • 481140 2022-016
    Significant Deficiency
  • 481141 2022-004
    Material Weakness Repeat
  • 481142 2022-005
    Material Weakness Repeat
  • 481143 2022-006
    Material Weakness Repeat
  • 481144 2022-007
    Significant Deficiency Repeat
  • 481145 2022-016
    Significant Deficiency
  • 481146 2022-004
    Material Weakness Repeat
  • 481147 2022-005
    Material Weakness Repeat
  • 481148 2022-006
    Material Weakness Repeat
  • 481149 2022-010
    Significant Deficiency Repeat
  • 481150 2022-014
    Material Weakness
  • 481151 2022-015
    Significant Deficiency
  • 481152 2022-016
    Significant Deficiency
  • 1057555 2022-004
    Material Weakness Repeat
  • 1057556 2022-005
    Material Weakness Repeat
  • 1057557 2022-006
    Material Weakness Repeat
  • 1057558 2022-007
    Significant Deficiency Repeat
  • 1057559 2022-009
    Material Weakness Repeat
  • 1057560 2022-010
    Significant Deficiency Repeat
  • 1057561 2022-011
    Significant Deficiency Repeat
  • 1057562 2022-004
    Material Weakness Repeat
  • 1057563 2022-005
    Material Weakness Repeat
  • 1057564 2022-006
    Material Weakness Repeat
  • 1057565 2022-007
    Significant Deficiency Repeat
  • 1057566 2022-009
    Material Weakness Repeat
  • 1057567 2022-010
    Significant Deficiency Repeat
  • 1057568 2022-011
    Significant Deficiency Repeat
  • 1057569 2022-004
    Material Weakness Repeat
  • 1057570 2022-005
    Material Weakness Repeat
  • 1057571 2022-006
    Material Weakness Repeat
  • 1057572 2022-007
    Significant Deficiency Repeat
  • 1057573 2022-012
    Significant Deficiency
  • 1057574 2022-013
    Significant Deficiency
  • 1057575 2022-016
    Significant Deficiency
  • 1057576 2022-017
    Significant Deficiency
  • 1057577 2022-004
    Material Weakness Repeat
  • 1057578 2022-005
    Material Weakness Repeat
  • 1057579 2022-006
    Material Weakness Repeat
  • 1057580 2022-008
    Significant Deficiency Repeat
  • 1057581 2022-009
    Material Weakness Repeat
  • 1057582 2022-016
    Significant Deficiency
  • 1057583 2022-004
    Material Weakness Repeat
  • 1057584 2022-005
    Material Weakness Repeat
  • 1057585 2022-006
    Material Weakness Repeat
  • 1057586 2022-007
    Significant Deficiency Repeat
  • 1057587 2022-016
    Significant Deficiency
  • 1057588 2022-004
    Material Weakness Repeat
  • 1057589 2022-005
    Material Weakness Repeat
  • 1057590 2022-006
    Material Weakness Repeat
  • 1057591 2022-010
    Significant Deficiency Repeat
  • 1057593 2022-015
    Significant Deficiency
  • 1057594 2022-016
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $4.41M
93.788 Opioid Str $1.46M
93.217 Family Planning_services $1.34M
10.557 Special Supplemental Nutrition Program for Women, Infants, and Children $1.29M
93.914 Hiv Emergency Relief Project Grants $898,253
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $584,947
93.837 Cardiovascular Diseases Research $402,416
93.917 Hiv Care Formula Grants $367,131
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $178,078
93.994 Maternal and Child Health Services Block Grant to the States $169,521
93.268 Immunization Cooperative Agreements $167,318
93.236 Grants to States to Support Oral Health Workforce Activities $104,190
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $81,214
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $77,935
93.889 National Bioterrorism Hospital Preparedness Program $33,398
93.279 Drug Abuse and Addiction Research Programs $31,446
93.297 Teenage Pregnancy Prevention Program $14,271
93.855 Allergy, Immunology and Transplantation Research $1,571